Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) Market
Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) , historical and forecasted epidemiology as well as the Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the PH-ILD facts:
According to Somnath Pal et al., 12 million people in the United States are affected by interstitial lung disease.
According to the study conducted by Boris Duchemann et al., prevalence of sarcoidosis was found out to be 30.2 per 100,000, prevalence of connective tissue diseases associated ILDs was found out to be 12.1 per 100,000 and prevalence of idiopathic pulmonary fibrosis was found out to be 8.2 per 100,000.